Table 4.
Logistic regression model: predictors of poor functional outcome at 3 months of all cohort.
| OR (IC 95%) | p-value | |
|---|---|---|
| Age | 1.04 (1.02–1.05) | <0.001 |
| Sex (women) | 1 (0.75–1.32) | 0.99 |
| Arterial hypertension | 1.20 (0.89–1.60) | 0.21 |
| Diabetes mellitus | 1.21 (0.86–1.70) | 0.26 |
| Prior mRS | 1.61 (1.31–1.98) | <0.001 |
| Baseline NIHSS | 1.09 (1.07–1.11) | <0.001 |
| Vessel occlusion MCA-M1 | 1.06 (0.95–1.17) | 0.27 |
| VKA treatment | 1.13 (0.76–1.67) | 0.52 |
| ASPECTS | 0.73 (0.66–0.81) | <0.001 |
| Atrial fibrillation | 0.92 (0.77–1.10) | 0.39 |
| Onset-to-door time | 1 (0.99–1) | 0.68 |
mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale; MCA, middle cerebral artery; VKA, vitamin K antagonist; ASPECTS, Alberta Stroke Program Early CT Score.